Sarah Tucci, PA
Physician Assistant · Shreveport, LANPI 1982989265
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 261 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,086 and has fallen 70.3% since, to $619 in 2025. Among physician assistant clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 261 payments — averaging $24.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- AbbVie$1K
- Johnson & Johnson$793
- Novartis$684
- Endo USA, Inc.$198
- Teleflex LLC$196
- plus $2K from 27 others
What the payments were for
- Food & beverage$6,371100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 58 | $1,509 |
| AbbVie | 48 | $1,028 |
| Johnson & Johnson | 39 | $793 |
| Novartis | 19 | $684 |
| Endo USA, Inc. | 7 | $198 |
| Teleflex LLC | 1 | $196 |
| Bayer | 11 | $192 |
| Dendreon Pharmaceuticals LLC | 4 | $163 |
| Sun Pharmaceutical Industries Inc. | 7 | $153 |
| AstraZeneca(2 entities) | 8 | $143 |
| Procept Biorobotics Corporation | 1 | $142 |
| Sumitomo Pharma America, Inc. | 6 | $134 |
| Lilly USA, LLC | 5 | $119 |
| Astellas Pharma US Inc | 5 | $85 |
| Pfizer | 5 | $76 |
| Mallinckrodt Hospital Products Inc. | 4 | $75 |
| Abbott | 3 | $72 |
| Endo Pharmaceuticals Inc. | 4 | $66 |
| Axonics, Inc. | 2 | $61 |
| Pacira Therapeutics, Inc. | 2 | $57 |
| Progenics Pharmaceuticals, Inc. | 2 | $52 |
| Genentech USA, Inc. | 3 | $49 |
| Radius Health, Inc. | 2 | $45 |
| Tolmar, Inc. | 2 | $45 |
| UCB, Inc. | 3 | $45 |
| Myriad Genetic Laboratories, Inc. | 2 | $36 |
| Photocure Inc | 2 | $34 |
| Telix Pharmaceuticals | 1 | $29 |
| Ferring Pharmaceuticals Inc. | 1 | $22 |
| 180 Medical, Inc. | 1 | $20 |
| Bioprotect Medical, Inc. | 1 | $20 |
| GSK | 1 | $14 |
| Halozyme Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,371 in reported general payments places this provider in the 95th percentile of 1,246 physician assistant providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 68 | $31,656 |
| GemtesaVibegron | 27 | $14,784 |
| Cefdinir | 215 | $8,982 |
| Mirabegron ErMirabegron | 25 | $8,921 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 176 | $8,521 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 261 | $5,872 |
| Tamsulosin Hcl | 393 | $5,262 |
| Methenamine Hippurate | 88 | $4,294 |
| Cefaclor | 19 | $3,128 |
| Finasteride | 191 | $2,129 |
| Doxycycline Hyclate | 121 | $1,938 |
| Estradiol | 29 | $1,665 |
| Ciprofloxacin Hcl | 114 | $1,236 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 42 | $913 |
| Hydroxychloroquine Sulfate | 27 | $768 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $85 | $31,65668 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $134 | $14,78427 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,246 physician assistant providers in Louisiana.
Other physician assistant in Shreveport
- Emily BergeronShreveport$17K
- Seth MillerShreveport$16K
- Cassie MillerShreveport$16K
- Cedric WillisShreveport$12K
- Sarah HutchinsonShreveport$12K
- Megan JohnsonShreveport$12K
- Dustin HadleyShreveport$11K
- Shannon KoveleskieShreveport$9K
- Colleen ClineShreveport$8K
- Jennifer BrownShreveport$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.